Evidence map›Paper›PMID 40108041›Full record

ArticleEuropean journal of pediatrics2025

The MNK-SYNGAP1 axis in specific learning disorder: gene expression pattern and new perspectives.

Cansu Mercan Isik, Elif Burcu Tuzemen Bayyurt, Nil Ozbilum Sahin

Erratum issuedAbstract read
In one paragraph

Article in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Increased Agmatine Degradation in Children with Specific Learning Disorder.International journal of molecular sciences · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Research progress inFrontiers in neurology
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Cansu Mercan IsikDepartment of Child and Adolescent Psychiatry, Faculty of Medicine, Cumhuriyet University, Sivas, Turkey. dr.cansumercan@gmail.com.ORCID http://orcid.org/0000-0001-9437-3024
Elif Burcu Tuzemen BayyurtDepartment of Medical Biology, Faculty of Medicine, Cumhuriyet University, 58140, Sivas, Turkey.
Nil Ozbilum SahinDepartment of Molecular Biology and Genetic, Faculty of Science, Cumhuriyet University, 58140, Sivas, Turkey.

Funding

Sivas Cumhuriyet Üniversitesi , Türkiye T-2024-1031
6 · The paper itself

Abstract

Specific learning disorder (SLD) is a neurodevelopmental disorder that significantly affects children's academic performance. This study aimed to investigate the expression levels of the MAP Kinase Interacting Serine/Threonine Kinase 1-2 (MNK1, MNK2), Synaptic Ras GTPase Activating Protein 1 (SYNGAP1) genes, and the long non-coding RNA Synaptic Ras GTPase Activating Protein 1-Anti Sense1 (SYNGAP1-AS1), which are believed to play a key role in neurodevelopmental pathways, in children with SLD. Understanding the role of these genes in synaptic plasticity and cognitive function may provide insights into the molecular mechanisms underlying SLD. This study included 38 children diagnosed with SLD and 35 healthy controls aged 6 to 16. RNA was isolated from blood samples, and gene expression levels were measured using quantitative polymerase chain reaction (qPCR). The statistical analysis was conducted to compare the expression levels between the SLD and control groups and within SLD subgroups based on severity and sex. MNK1 and SYNGAP1 expression levels were significantly upregulated in the SLD group compared to the control group (8.33-fold and 16.52-fold increase, respectively; p < 0.001). lncSYNGAP1-AS1 showed a 26.58-fold increase, while MNK2 was downregulated by 2.2-fold, although these changes were not statistically significant. No significant differences were observed between sexes or between the severity subgroups of SLD.

conclusionhe upregulation of MNK1 and SYNGAP1 in children with SLD suggests their involvement in the neurodevelopmental pathways associated with cognitive processes such as learning and memory. These findings provide a foundation for future research into the molecular basis and potential therapeutic targets of SLD. WHAT IS KNOWN: • SYNGAP1 is a key regulator of synaptic plasticity and learning, primarily functioning through Ras signaling inhibition. Its deficiency impairs long-term potentiation (LTP) and is associated with neurodevelopmental disorders (NDDs) such as autism spectrum disorder (ASD) and intellectual disability. • The MAPK/ERK pathway plays a crucial role in learning and memory, and its dysregulation has been linked to several neurological conditions. MNK1/2 interacts with SYNGAP1 in synaptic signaling. WHAT IS NEW: • This study is the first to demonstrate significant upregulation of SYNGAP1 and MKNK1 in children with SLD. • Understanding the role of the MKNK-SYNGAP1 axis may guide the development of targeted therapies aimed at enhancing synaptic plasticity to improve learning and memory outcomes in children with SLD.

Indexed as

Intracellular Signaling Peptides and ProteinsLearning DisabilitiesProtein Serine-Threonine Kinasesras GTPase-Activating ProteinsAdolescentCase-Control StudiesChildFemaleHumansMaleUp-RegulationIntracellular Signaling Peptides and ProteinsMKNK1 protein, humanMKNK2 protein, humanProtein Serine-Threonine Kinasesras GTPase-Activating ProteinsSYNGAP1 protein, humanGene expressionMNK1QPCRSLDSYNGAP1

Identifiers

PMID40108041
PMCPMC11922980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.